Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Multiple Sclerosis
Multiple Sclerosis
FDA Approves Generic Option for Relapsing Forms of MS
10/04/2017
The FDA has approved a generic option for the treatment of patients with relapsing forms of multiple sclerosis. For details, including dosage and common adverse effects, read more.
10/04/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves New Fast-Acting Insulin
09/29/2017
The FDA has approved a new option for glycemic control in adults with type 1 and type 2 diabetes. For details, including dosing and adverse events, read more.
09/29/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves New Fast-Acting Insulin
09/29/2017
The FDA has approved a new option for glycemic control in adults with type 1 and type 2 diabetes. For details, including dosing and adverse events, read more.
09/29/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves New Fast-Acting Insulin
09/29/2017
The FDA has approved a new option for glycemic control in adults with type 1 and type 2 diabetes. For details, including dosing and adverse events, read more.
09/29/2017
Diabetes Q&A
Diabetes Q&A
Newly Approved Continuous Glucose Monitoring System Does Not Require Fingerstick
09/28/2017
The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.
09/28/2017
Diabetes Q&A
Diabetes Q&A
Newly Approved Continuous Glucose Monitoring System Does Not Require Fingerstick
09/28/2017
The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.
09/28/2017
Diabetes Q&A
Diabetes Q&A
Newly Approved Continuous Glucose Monitoring System Does Not Require Fingerstick
09/28/2017
The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.
09/28/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017
Oncology
Oncology
FDA Expands Nivolumab Approval for Type of Liver Cancer
09/25/2017
The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.
09/25/2017